NCT06692192View on ClinicalTrials.gov

The RECAP2 Study: Midazolam and Psilocybin

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 7, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Psilocybin
Interventions
DRUG

Psilocybin

25mg of psilocybin

DRUG

Psilocybin

1mg of psilocybin

DRUG

Midazolam

The goal of the midazolam dosing regimen is to induce amnesia of the psychedelic experience without inducing over-sedation during the dosing session.

DRUG

Saline

Saline will be administered as a placebo for midazolam

Trial Locations (1)

53792

RECRUITING

UW School of Medicine and Public Health, Madison

All Listed Sponsors
collaborator

Vail Health Foundation

UNKNOWN

lead

University of Wisconsin, Madison

OTHER